Slowed S phase progression and senescence entry is the prominent cell cycle effect of IFN-β in various types of human solid tumor cells, not the G1/G0 growth arrest observed in hematopoietic cancer cells (19, 39). This evidence concerns the gene IFNB1 and hematopoietic and lymphoid cell neoplasm.